Bio-Rad will maintain Hematronix's operations in Plano, Texas, while research and development, manufacturing and distribution activities will continue in Benicia, California.
Bio-Rad Laboratories has purchased the majority of assets of Hematronix of Plano, Texas.
Bio-Rad will acquire the company's line of quality control products and services.
Terms of the sale have not been disclosed.
"This acquisition further enhances our leadership position in the area of quality control products that are integral to the accurate diagnosis of a wide variety of maladies," said Bio-Rad president and CEO Norman Schwartz.
Bio-Rad will maintain Hematronix's operations in Plano, Texas, while research and development, manufacturing and distribution activities will continue in Benicia, California.
Hematronix is a private company that supplies quality control and quality assurance products and services to the clinical diagnostics industry.
The company is a full line manufacturer of hematology and urine controls, hematology reagents and regulatory products and services.
Bio-Rad offers a broad selection of quality control products that enable clinical laboratories to provide consistent and reliable patient testing results.
Products include controls for hundreds of diagnostic analytes, sophisticated data management software and internet-based programs for quality control data reporting and comparative performance analysis.
